1.16
price up icon2.65%   0.03
after-market アフターアワーズ: 1.14 -0.02 -1.72%
loading
前日終値:
$1.13
開ける:
$1.12
24時間の取引高:
559.79K
Relative Volume:
1.05
時価総額:
$71.83M
収益:
$248.00K
当期純損益:
$-113.22M
株価収益率:
-0.6299
EPS:
-1.8416
ネットキャッシュフロー:
$-98.81M
1週間 パフォーマンス:
+4.50%
1か月 パフォーマンス:
+10.48%
6か月 パフォーマンス:
-10.08%
1年 パフォーマンス:
-28.83%
1日の値動き範囲:
Value
$1.11
$1.185
1週間の範囲:
Value
$1.0932
$1.185
52週間の値動き範囲:
Value
$1.02
$1.95

Pliant Therapeutics Inc Stock (PLRX) Company Profile

Name
名前
Pliant Therapeutics Inc
Name
セクター
Healthcare (1074)
Name
電話
650-481-6770
Name
住所
331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA
Name
職員
49
Name
Twitter
Name
次回の収益日
2026-08-06
Name
最新のSEC提出書
Name
PLRX's Discussions on Twitter

Compare PLRX vs VRTX, REGN, ARGX, MRNA, RVMD

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
PLRX icon
PLRX
Pliant Therapeutics Inc
1.16 69.35M 248.00K -113.22M -98.81M -1.8416
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
546.12 136.93B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
827.72 85.11B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
1,033.15 64.95B 4.16B 1.29B 734.26M 19.58
MRNA icon
MRNA
Moderna Inc
145.55 53.23B 2.23B -3.19B -1.60B -8.1462
RVMD icon
RVMD
Revolution Medicines Inc
210.02 45.38B 742.00K -1.37B -1.07B -7.0731

Pliant Therapeutics Inc Stock (PLRX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-10-10 ダウングレード JP Morgan Neutral → Underweight
2025-03-04 再開されました Cantor Fitzgerald Neutral
2025-03-04 ダウングレード Needham Buy → Hold
2025-03-03 ダウングレード Leerink Partners Outperform → Market Perform
2025-03-03 ダウングレード Stifel Buy → Hold
2025-02-10 ダウングレード Canaccord Genuity Buy → Hold
2025-02-10 ダウングレード Citigroup Buy → Neutral
2025-02-10 ダウングレード H.C. Wainwright Buy → Neutral
2025-02-10 ダウングレード JP Morgan Overweight → Neutral
2025-02-10 ダウングレード Oppenheimer Outperform → Perform
2025-02-10 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2025-02-10 ダウングレード Wells Fargo Overweight → Equal Weight
2024-09-09 再開されました Leerink Partners Outperform
2023-12-08 開始されました Wells Fargo Overweight
2023-05-18 開始されました Canaccord Genuity Buy
2023-04-13 開始されました Robert W. Baird Outperform
2022-12-14 開始されました Stifel Buy
2022-12-07 開始されました JP Morgan Overweight
2022-09-01 開始されました Citigroup Buy
2022-07-20 開始されました SVB Leerink Outperform
2022-05-25 開始されました Cantor Fitzgerald Overweight
2021-12-10 開始されました Oppenheimer Outperform
2021-11-24 開始されました RBC Capital Mkts Outperform
2021-11-03 開始されました H.C. Wainwright Buy
2021-04-20 開始されました BTIG Research Buy
2021-04-05 開始されました Citigroup Buy
2020-06-29 開始されました Citigroup Buy
2020-06-29 開始されました Cowen Outperform
2020-06-29 開始されました Needham Buy
2020-06-29 開始されました Piper Sandler Overweight
すべてを表示

Pliant Therapeutics Inc (PLRX) 最新ニュース

pulisher
Aug 21, 2026

Price to earnings forward of Pliant Therapeutics, Inc. – DUS:9PT - TradingView

Aug 21, 2026
pulisher
Aug 19, 2026

Pliant (PLRX) Watch: Finishes 1.74% Up at $1.17 at the Close; Technical View: the $1.11 to $1.23 Range Remains in Focus in the Available RecordUnusual Put Volume - vinanet.vn

Aug 19, 2026
pulisher
Aug 18, 2026

symbol__ Stock Quote Price and Forecast - CNN

Aug 18, 2026
pulisher
Aug 18, 2026

Why is Pliant Therapeutics stock climbing today? - Investing.com

Aug 18, 2026
pulisher
Aug 18, 2026

Why is Pliant Therapeutics stock climbing today? By Investing.com - Investing.com India

Aug 18, 2026
pulisher
Aug 18, 2026

Pliant Therapeutics (PLRX) Gains FDA Fast Track for PLN-101095 A - GuruFocus

Aug 18, 2026
pulisher
Aug 18, 2026

Pliant Therapeutics receives FDA fast track for cancer drug - Investing.com

Aug 18, 2026
pulisher
Aug 18, 2026

Pliant Therapeutics Receives FDA Fast Track Designation for PLN-101095 in Combination with Pembrolizumab for the Treatment of ICI-Refractory Solid Tumors - The Manila Times

Aug 18, 2026
pulisher
Aug 18, 2026

Pliant Therapeutics Receives FDA Fast Track Designation for - GlobeNewswire

Aug 18, 2026
pulisher
Aug 18, 2026

J.P. Morgan Maintains Pliant Therapeutics(PLRX.US) With Sell Rating - Moomoo

Aug 18, 2026
pulisher
Aug 18, 2026

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Given Consensus Recommendation of "Reduce" by Brokerages - MarketBeat

Aug 18, 2026
pulisher
Aug 18, 2026

Pliant wins FDA Fast Track status for PLN-101095 plus Keytruda in ICI-refractory solid tumors - Bitget

Aug 18, 2026
pulisher
Aug 17, 2026

Pliant Therapeutics (PLRX) Advances Clinical Program Amidst Chal - GuruFocus

Aug 17, 2026
pulisher
Aug 17, 2026

Monaco Asset Management SAM Purchases Shares of 1,938,747 Pliant Therapeutics, Inc. $PLRX - MarketBeat

Aug 17, 2026
pulisher
Aug 15, 2026

Pliant Therapeutics Inc (FRA:9PT) Stock Price, Trades & News - GuruFocus

Aug 15, 2026
pulisher
Aug 15, 2026

Pliant Therapeutics (PLRX) Slips to $1.07, Testing Critical Support ZoneMutual Fund Flow - dars.gov.et

Aug 15, 2026
pulisher
Aug 15, 2026

Pliant Therapeutics (NASDAQ:PLRX) Downgraded by Wall Street Zen to Sell - MarketBeat

Aug 15, 2026
pulisher
Aug 14, 2026

Pliant Therapeutics (PLRX) gains 8.9% institutional holder in ADAR1 Capital - Stock Titan

Aug 14, 2026
pulisher
Aug 14, 2026

Pliant Therapeutics (PLRX): Citadel entities, Kenneth Griffin report 3.5% holding - Stock Titan

Aug 14, 2026
pulisher
Aug 14, 2026

Pliant Therapeutics (PLRX) Institutional Ownership 2026 $PLRX - MarketBeat

Aug 14, 2026
pulisher
Aug 13, 2026

Price performance - Yahoo Finance Australia

Aug 13, 2026
pulisher
Aug 13, 2026

CCORF Maintains Pliant Therapeutics(PLRX.US) With Hold Rating, Maintains Target Price $3 - Moomoo

Aug 13, 2026
pulisher
Aug 13, 2026

RBC Capital Sticks to Their Hold Rating for Pliant Therapeutics (PLRX) - The Globe and Mail

Aug 13, 2026
pulisher
Aug 12, 2026

PLRX (Pliant Therapeutics) 12-1 Month Momentum % : -30.79% (As of Aug. 17, 2026) - GuruFocus

Aug 12, 2026
pulisher
Aug 12, 2026

Form 8K Pliant Therapeutics Inc For: 11 August By Investing.com - Investing.com India

Aug 12, 2026
pulisher
Aug 11, 2026

Pliant Therapeutics cuts Q2 loss to $22.4M on lower costs - scanx.trade

Aug 11, 2026
pulisher
Aug 11, 2026

Pliant Therapeutics (NASDAQ:PLRX) Posts Earnings Results, Misses Estimates By $0.02 EPS - MarketBeat

Aug 11, 2026
pulisher
Aug 11, 2026

Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results - The Manila Times

Aug 11, 2026
pulisher
Aug 11, 2026

Pliant Therapeutics (PLRX) halves quarterly loss and reports $159.6M in cash reserves - Stock Titan

Aug 11, 2026
pulisher
Aug 11, 2026

BRIEF-Pliant Therapeutics Q2 Net Income USD -22.371 Million - TradingView

Aug 11, 2026
pulisher
Aug 11, 2026

Pliant Therapeutics (PLRX) Earnings Date and Reports 2026 $PLRX - MarketBeat

Aug 11, 2026
pulisher
Aug 10, 2026

Pliant Therapeutics Q1 2026 Earnings: Narrower Loss Beats Estimates as Fibrosis Pipeline AdvancesMargin Improvement Report - vinanet.vn

Aug 10, 2026
pulisher
Aug 09, 2026

Pliant Therapeutics Inc (PLRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Aug 09, 2026
pulisher
Aug 07, 2026

Pliant Therapeutics Inc (PLRX) Stock News Today - TradingKey

Aug 07, 2026
pulisher
Aug 03, 2026

Pliant Therapeutics, Inc. expected to post a loss of 34 cents a shareEarnings Preview - TradingView

Aug 03, 2026
pulisher
Jul 30, 2026

Pliant Therapeutics (PLRX) Expected to Release Quarterly Earnings on Thursday - MarketBeat

Jul 30, 2026
pulisher
Jul 29, 2026

Pliant Therapeutics (PLRX) Holds Near Support Amid Modest DeclineLinear Regression - vinanet.vn

Jul 29, 2026
pulisher
Jul 28, 2026

Pliant Therapeutics (PLRX) Edges Higher Amid Tight Trading Range — Key Levels in FocusStandard Deviation - dars.gov.et

Jul 28, 2026
pulisher
Jul 27, 2026

Pliant Therapeutics Inc (PLRX) Income Statement - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Pliant Therapeutics Inc (PLRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Pliant Therapeutics Inc (PLRX) Cash Flow - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Pliant Therapeutics Inc (PLRX) Balance Sheet - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Pliant Therapeutics Inc (PLRX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Pliant Therapeutics (PLRX) Slides Near Support as Selling Pressure ContinuesInsider Sentiment - vinanet.vn

Jul 27, 2026
pulisher
Jul 27, 2026

Pliant Therapeutics Inc (PLRX) Institutional Confidence - TradingKey

Jul 27, 2026
pulisher
Jul 25, 2026

Pliant Therapeutics Inc (PLRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 25, 2026
pulisher
Jul 25, 2026

PLRX|Pliant Therapeutics Inc|Price:1.080|Chg%:-0.010 - TradingKey

Jul 25, 2026
pulisher
Jul 25, 2026

PLRX|Pliant Therapeutics Inc|Price:1.090|Chg%:+0.010 - TradingKey

Jul 25, 2026
pulisher
Jul 24, 2026

Pliant Therapeutics Inc (PLRX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jul 24, 2026
pulisher
Jul 24, 2026

Pliant Therapeutics (PLRX) Holds Near Support as Biotech Stock Stalls at $1.08Block Trade Flow - vinanet.vn

Jul 24, 2026
pulisher
Jul 21, 2026

Pliant Therapeutics (NASDAQ:PLRX) Trading Down 7%Here's Why - MarketBeat

Jul 21, 2026

Pliant Therapeutics Inc (PLRX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Pliant Therapeutics Inc (PLRX) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Cheung Lily
Chief Human Resource Officer
Jan 20 '26
Sale
1.28
7,534
9,644
44,847
Coulie Bernard
President and CEO
Jan 20 '26
Sale
1.28
89,375
114,400
505,601
Kuo Minnie
Chief Operating Officer
Jan 20 '26
Sale
1.28
6,917
8,854
37,806
$103.76
price up icon 0.86%
$126.29
price down icon 0.31%
$63.96
price up icon 0.13%
$266.11
price up icon 0.61%
ONC ONC
$358.26
price down icon 1.22%
$210.02
price down icon 0.40%
大文字化:     |  ボリューム (24 時間):